Sign in

CIK 0001680581 · Non-accelerated filer<br>Smaller reporting company

Fulcrum Therapeutics, Inc.

Sign in to watch
Ticker
FULC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
474839948
Phone
617-651-8851
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. 8-K Event Exit or restructuring costs · Other events
  3. 8-K Event Other events
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. 4 Insider Changes in Ownership
  7. 3 Insider Initial Statement of Ownership
  8. DEFA14A Proxy Proxy Materials
  9. ARS Other Annual Report to Security Holders
  10. DEF 14A Proxy Proxy Statement
  11. 10-Q Report Quarterly Report
  12. 8-K Event Agreement ended · Results of operations · Executive or director change
  13. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  14. S-8 Other Securities Offered to Employees in Benefit Plans
  15. 10-K Report Annual Report
  16. 8-K Event Results of operations
  17. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  18. 4/A Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 3 of 26 · 520 filings